Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHA:600488)
China · Delayed Price · Currency is CNY 4.720
-0.210 (-4.26%)
Nov 13, 2026, 3:00 PM CST
SHA:600488 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 719.01 | 824.6 | 638.46 | 718.86 | 647.74 | 232.22 |
Cash & Short-Term Investments | 719.01 | 824.6 | 638.46 | 718.86 | 647.74 | 232.22 |
Cash Growth | 11.68% | 29.15% | -11.18% | 10.98% | 178.94% | -4.97% |
Accounts Receivable | 727.02 | 723.35 | 459.12 | 578.33 | 498.17 | 596.38 |
Other Receivables | 12.29 | 38.08 | 22.64 | 30.8 | 27.09 | 30.75 |
Receivables | 739.32 | 761.44 | 481.76 | 609.13 | 525.26 | 627.13 |
Inventory | 506.62 | 583.84 | 651.92 | 725.58 | 1,158 | 975.64 |
Prepaid Expenses | - | 0.7 | 1.15 | - | - | - |
Other Current Assets | 39.71 | 25.58 | 31.18 | 54.5 | 29.96 | 47.58 |
Total Current Assets | 2,005 | 2,196 | 1,804 | 2,108 | 2,360 | 1,883 |
Property, Plant & Equipment | 2,665 | 2,677 | 2,875 | 3,069 | 3,174 | 3,348 |
Long-Term Investments | 254.78 | 249.75 | 227.88 | 164.2 | 307.15 | 360.64 |
Other Intangible Assets | 382.58 | 388.59 | 349.66 | 303.66 | 254.61 | 192.38 |
Long-Term Deferred Tax Assets | 55.15 | 50.78 | 28.88 | 41.81 | 40.38 | 32.1 |
Long-Term Deferred Charges | 119.55 | 120.51 | 180.91 | 168.41 | 175.11 | 150.97 |
Other Long-Term Assets | 76.3 | 77.26 | 231.49 | 287.15 | 338.69 | 378.31 |
Total Assets | 5,558 | 5,760 | 5,698 | 6,142 | 6,651 | 6,345 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 595.97 | 575.28 | 638.69 | 719.55 | 792.9 | 565.94 |
Accrued Expenses | 87.52 | 173.83 | 184.5 | 161.15 | 84.33 | 64.77 |
Short-Term Debt | 98.06 | 167.87 | 108.58 | 270.25 | 648.34 | 588.63 |
Current Portion of Long-Term Debt | 419.48 | 32.44 | 0.2 | 404.59 | 295.83 | 421.09 |
Current Portion of Leases | - | 0.16 | 0.17 | 0.11 | 0.38 | 30.27 |
Current Income Taxes Payable | 35.29 | 6.74 | 0.87 | 0.85 | 1.65 | 16.7 |
Current Unearned Revenue | 42.83 | 52.73 | 79.73 | 137.19 | 134.11 | 68.35 |
Other Current Liabilities | 138.41 | 158.2 | 202.27 | 246.6 | 322.55 | 267.8 |
Total Current Liabilities | 1,418 | 1,167 | 1,215 | 1,940 | 2,280 | 2,024 |
Long-Term Debt | 103.44 | 535.11 | 424.6 | 277 | 458.64 | 367.24 |
Long-Term Leases | 20.57 | 0.09 | 0.11 | - | 0.12 | 0.27 |
Long-Term Unearned Revenue | 125.94 | 132.41 | 140.83 | 144.99 | 117.7 | 89.56 |
Long-Term Deferred Tax Liabilities | 33.59 | 29.86 | 27.96 | 18.12 | 39.3 | 47.53 |
Other Long-Term Liabilities | 0.24 | 0.24 | 3.92 | 8.77 | 1.01 | - |
Total Liabilities | 1,701 | 1,865 | 1,812 | 2,389 | 2,897 | 2,528 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,092 | 1,092 | 1,092 | 1,094 | 1,096 | 1,100 |
Additional Paid-In Capital | 372.9 | 320.99 | 320.32 | 322.19 | 327.1 | 335.01 |
Retained Earnings | 1,428 | 1,493 | 1,534 | 1,495 | 1,389 | 1,369 |
Treasury Stock | - | - | - | -4.73 | -10.34 | -18.85 |
Comprehensive Income & Other | 134.26 | 128.5 | 111.41 | 46.95 | 170.35 | 207.88 |
Total Common Equity | 3,027 | 3,034 | 3,057 | 2,954 | 2,973 | 2,993 |
Minority Interest | 829.97 | 860.41 | 828.52 | 799.75 | 781.33 | 823.83 |
Shareholders' Equity | 3,857 | 3,895 | 3,886 | 3,753 | 3,754 | 3,817 |
Total Liabilities & Equity | 5,558 | 5,760 | 5,698 | 6,142 | 6,651 | 6,345 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 641.55 | 735.67 | 533.66 | 951.96 | 1,403 | 1,407 |
Net Cash (Debt) | 77.45 | 88.93 | 104.8 | -233.1 | -755.57 | -1,175 |
Net Cash Growth | - | -15.14% | - | - | - | - |
Net Cash Per Share | 0.07 | 0.08 | 0.10 | -0.21 | -0.68 | -1.09 |
Filing Date Shares Outstanding | 1,092 | 1,092 | 1,092 | 1,094 | 1,096 | 1,100 |
Total Common Shares Outstanding | 1,092 | 1,092 | 1,092 | 1,094 | 1,096 | 1,100 |
Working Capital | 587.09 | 1,029 | 589.46 | 167.77 | 80.39 | -140.98 |
Book Value Per Share | 2.77 | 2.78 | 2.80 | 2.70 | 2.71 | 2.72 |
Tangible Book Value | 2,644 | 2,646 | 2,708 | 2,650 | 2,718 | 2,801 |
Tangible Book Value Per Share | 2.42 | 2.42 | 2.48 | 2.42 | 2.48 | 2.55 |
Buildings | - | 2,285 | 2,290 | 2,277 | 2,198 | 1,792 |
Machinery | - | 2,580 | 2,565 | 2,541 | 2,405 | 2,149 |
Construction In Progress | - | 65.79 | 44.52 | 34.44 | 126.71 | 544.34 |